David Blaustein, MD

Dr. Blaustein is Managing Director of Healthcare at SuttonBrook Capital Management. He also serves as the Chief Scientific Advisor for Solving Kids Cancer (SKC), a pediatric oncology foundation which presently has five ongoing Phase I/II trials.

Dr. Blaustein started his finance career at Goldman Sachs and Zweig-Dimenna Associates. Before coming to Wall Street, David was an Assistant Professor of Medicine and Surgery at Yale University School of Medicine and a director of the American Heart Association. David holds an M.B.A. from The Wharton School, and a B.S. from the University of Pennsylvania, as well as an M.D. from the Weill Medical College, Cornell University. He is a past advisor to the journal Nature: Drug Discovery.